First Moscow State Medical University n.a. Sechenov

Moscow 119991

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Migraine, Psoriasis

Studies at this site

• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed
• A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis — Completed